Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving the Prognostic Accuracy of Staging Rectal Cancer Using Magnetic Resonance Imaging (MRI) - Detected Tumour Deposits and Vascular Invasion (mrTDV) Instead of Tumour Nodal Metastasis (mrTNM)

NCT07054047 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT07054047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07054047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving the Prognostic Accuracy of Staging Rectal Cancer Using Magnetic Resonance Imaging (MRI) - Detected Tumour Deposits and Vascular Invasion (mrTDV) Instead of Tumour Nodal Metastasis (mrTNM)
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
May 31, 2031
Enrollment
438 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

gi cancer